WELL Health TechnologiesWHTCF 76 3-Year RORE % is 7.89 as of Mar. 2026. GuruFocus rates WHTCF with a GF Score™ of 76/100 and a GF Value™ of $5.16 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 606 Healthcare Providers & Services companies, WELL Health Technologies ranks better than 59.9% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
WELL Health Technologies's 3-Year RORE % for the quarter that ended in Mar. 2026 was 7.89%.
The industry rank for WELL Health Technologies's 3-Year RORE % or its related term are showing as below:
WHTCF's 3-Year RORE % is ranked better than 59.9% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 0.56
vs WHTCF: 7.89
WELL Health Technologies (OTCPK:WHTCF) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
WELL Health Technologies 3-Year RORE % Related Terms
WELL Health Technologies 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, WELL Health Technologies's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WELL Health Technologies 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, WELL Health Technologies's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where WELL Health Technologies's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
WELL Health Technologies (WHTCF) has a 3-Year RORE % of 7.89 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on WELL Health Technologies and its competitors. According to the industry distribution chart, WELL Health Technologies ranks #243 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 40.1%.
Is WELL Health Technologies' 3-Year RORE % too high?
WELL Health Technologies' current 3-Year RORE % is 7.89. The Healthcare Providers & Services industry median 3-Year RORE % is 0.56. WELL Health Technologies' value of 7.89 is 1308.9% above this industry median. Based on the distribution chart, WELL Health Technologies ranks #243 out of 606 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, WELL Health Technologies has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does WELL Health Technologies' 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, WELL Health Technologies ranks #243 out of 606 companies for 3-Year RORE %. This puts WELL Health Technologies in the upper half of its industry. The industry median 3-Year RORE % is 0.56. WELL Health Technologies' value of 7.89 is 1308.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.56, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WELL Health Technologies's current 3-Year RORE % of 7.89 is 1308.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on WELL Health Technologies and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WELL Health Technologies's current 3-Year RORE % is 7.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WELL Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, WELL Health Technologies (WHTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.16, compared to a current price of $2.92 — trading 43.4% below its estimated fair value. The current 3-Year RORE % is 7.89 and 1308.9% above the Healthcare Providers & Services industry median of 0.56. WELL Health Technologies' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For WELL Health Technologies (WHTCF), the current 3-Year RORE % is 7.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WELL Health Technologies (WHTCF) Overvalued in 2026?
Based on GuruFocus' analysis, WELL Health Technologies stock appears to be undervalued.
The current stock price of $2.92 is trading 43.4% below its estimated GF Value™ of $5.16.
GuruFocus considers WELL Health Technologies to be Possible Value Trap.
Key valuation signals for WHTCF:
3-Year RORE %: 7.89
GF Value™: $5.16 vs. price of $2.92 (43.4% below fair value)
Industry Position: 1308.9% above the Healthcare Providers & Services median (#243 of 606)
No single metric tells the full story. See the WHTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth; WELL Health USA Patient Services, which derives maximum revenue, includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing; SaaS and Technology Services provides digital health and infrastructure solutions for healthcare providers, including Electronic MedicalRecords (EMRs), patient engagement and eReferral solutions, AI-enabled applications, billing and practice management services, and cybersecurity protection and data privacy solutions; and HEALWELL: AI and data sciences and healthcare software offerings.
76GF Score
Get the complete analysis for WHTCF
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WHTCF has been successfully added to your 
